Home > Drug Search >
  • Status: IND Filing
  •   > 
Drug Filter
Category:
chemistry (55) biology (51)
Clinical Stage:
Pending (3) Active (79) Discontinued (1)
Bio-Type:
CAR T cell therapy (2) Oncolytic virus (1) Recombinant enzyme (1) Recombinant cytokines (4) Recombinant hormone (2) Bispecific antibody (2) Whole antibody (25) ADC (3) Fusion protein (2)
Company:
Hansoh Pharma (1) Jiangsu Hengrui Medicine (5) Lee's Pharm (1) Merck Serono (1) National Cancer Institute (1) Sanofi (1) Five Prime Therapeutics (1) Kite Pharma (1) Generon Corporation (1) Innovent Biologics (2) Shanghai Biomabs (2) Shanghai Henlius Biotech (1) Alphamab (2) Tianjin SinoBiotech (1) Yantai Rongchang Biological Engineering (1) Genor Biopharma (3) Hualan Biological Engineering (1) Hisun Pharm (1) Qilu Pharmaceutical (1) Kelun Pharmaceutical (2) Suzhou Dawnrays Pharmaceutical (1) Penglai Nuokang Pharmaceutical (1) Zhaoke Pharmaceutical (1) XuanZhu Pharma (1) Fochon Pharmaceuticals (1) Institute of Pharmacology & Radiation of AMMS (1) Jiangxi Qingfeng Pharmaceutical (1) Beijing Fengshuo Weikang (1) Beijing ShuangLu Pharmaceutical (1) Shijiazhuang Zhongqi Pharmaceutical (3) Zhejiang Yongning Pharmaceutical (2) BBCA Pharmaceutical (1) Chongqing University of Arts and Sciences (1) Cisen Pharmaceutical (1) Tianjin Institute of Pharmaceutical Research (1) Jianfeng Pharmaceutical (1) Kanion Pharmaceutical (2) China State Institute of Pharmaceutical Industry (CSIPI) (1) Shanghai Genomics (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) Centaurus Biopharma (1) Institute of Pharmacology & Toxicology of AMMS (1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (1) China Pharmaceutical University (1) Fosun Pharma (1) ImQuest BioSciences (1) Shenyang Pharmaceutical University (1) 302 Military Hospital of China (1) Third Military Medical University (1) Tasly Pharm (1) Immune Pharmaceuticals (1) Bio-Thera Solutions (2) Shanghai Pharma (1) Chinese PLA General Hospital/Medical School of Chinese PLA (1) Shandong Provincial Institute of Dermatology and Venereology (1) Hangzhou Pharmavaxin (1) Guangzhou Yinnuo Pharmaceutical (1) Fujian Jinshon Biologicalpharmaceutical (1) Hangzhou Adamerck Pharmlabs (2) Shanghai Newsummit Biopharma (2) Shanghai Xianfu Chemical Technology (1) Ocean University of China (1) Peking University Health Science Center (1) Nanjing Tech University (1) 浙江浙北药业 (1) Zhejiang Forever Medicine (1) TOT Biopharm (1) Foreland Pharma (1) Ajanta Pharma (1) Jingfeng Pharma (1) Zhaoke Oncology (1) Shanghai Hengrui (2) Hangzhou Tianlong Pharmaceuticals (1) GNI Group (1) 吉林英联尚德科技开发 (1) Sichuan Saizhuo Pharmaceutical (1) Akeso Biopharma (1) Huabo Biopharm (1) Chongqing Fujin Biomedical (1) MabSpace Biosciences (1) Buchang Pharma (1) Dalian Dien Biological Engineering (1) Suzhou Kanger Biopharmaceutical (1) Anke Biotechnology (2) Foshan Ruidiao Pharmaceutical (1) NuoKang Biopharma (1) Beijing Ruiyunhai Biotechnology (1) Hefei Tianmai Biotechnology (1) 广东暨大基因药物工程研究中心 (1) Shanghai Institute of Biological Products (1) 浙江优诺金生物工程 (1) Shanghai Miracogen (1) Wuhan Boweid Biotechnology (1) 安徽未名达木生物医药 (1) Mab-Venture (1) 南京传奇生物科技 (1) CStone Pharmaceuticals (2) JHL Biotech (2) Wuhan Yicheng Biopharmaceutical (1) 重庆智翔金泰生物制药 (1) Zhejiang Teruisi Pharmaceutical (1) Teligene (1) Puyi chemical/Gyrochem (1) Signum Dermalogix (1) Dermata (1) Beijing Molike Technology (1) Chengdu Yiping Pharmaceutical Technology (1) Sichuan Yibin Wuliangye Yibin Pharmaceutical (1) Qingdao University (1) Wuhan Kangliyuan (1) Techfields Pharma (1) Shanghai De Novo Pharmatech (1) Beijing Collab Pharma (1) Heng Kang (1) Samjin (1) Gmax Biopharm (1) Shanghai Allist Pharmaceuticals (1) Chiatai Tianqing (CTTQ) (2)
Indication:
Acne (2) Acute lymphoblastic leukaemia (ALL) (2) Allergic rhinitis (AR) (1) Anemia (1) Arrhythmia (1) Brain ischemia (1) Breast cancer (4) Keratitis (1) Chronic lymphocytic leukemia (CLL) (2) Chronic pain (1) Cystic fibrosis (CF) (1) Endometrial cancer (1) Endometriosis (1) Epilepsy/Seizures (1) Erectile dysfunction (ED) (1) Eye disorders (1) Gastric cancer (5) Generalized tonic-clonic status epilepticus (GTCSE) (1) Glioblastoma multiforme (1) HBV infection (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hypercholesterolemia (1) Hyperlipidemia (1) Leukemia (1) Lung cancer (3) Melanoma (1) Metastatic colorectal cancer (CRC) (2) Multiple myeloma (MM) (3) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (2) Non small cell lung cancer (NSCLC) (3) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (2) Osteoarthritis (OA) (2) Osteoporosis (1) Ovarian cancer (2) Parkinson's disease (PD) (1) Postmenopausal osteoporosis (1) Psoriasis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (5) Corneal epithelial defects (1) Solid tumours (19) Stable plaque psoriasis (1) Tuberculosis (1) Type 2 diabetes (5) Venous thromboembolism (VTE) (1) Cardiac ischemic complications (1) Systemic bacterial infections (3) Chronic heart failure (1) Malignant Ascites (1) Age-related macular degeneration (AMD) (2) Urothelial cancer (1) Macular edema (1) B-cell lymphoma (1) Diabetes (1) Bone metastases from solid tumors (2) HER2-positive metastatic breast cancer (2) Hyperphosphatemia (1) Growth failure (1) Gram-positive bacterial infection (1) Gastrointestinal motility disorders (1) Ischemic stroke (2) Gout (1) Thrombosis (1) Non allergic rhinitis (1) Alopecia (1) Bacterial infection (1) Urinary tract stones (1) HER2-positive breast cancer (2) Hand-foot-and-mouth disease (HFMD) (1) Temporal epilepsy (1) Tumor imaging agent (1) Unspecified (6) Liver failure (1) hematological malignancies (1) Immunological disorders (1) Giant cell tumor of bone (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top